Skip to main content

Table 2 Survival for the Whole Group Patients

From: Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors

Group

Adjuvant chemo-radiotherapy (n = 156)

Adjuvant radiotherapy (n = 145)

P value

3-year

5-year

3-year

5-year

OS

96.15%

90.29%

91.02%

81.29%

0.060

DFS

91.59%

86.11%

80.67%

74.89%

0.004

  1. Abbreviations: OS overall survival, DFS disease-free survival
  2. #: calculated by Kaplan–Meier method